Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs

被引:35
作者
Ko, L [1 ]
Cardona, GR [1 ]
Iwasaki, T [1 ]
Bramlett, KS [1 ]
Burris, TP [1 ]
Chin, WW [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Dept Gene Regulat Bone & Inflammat Res, Indianapolis, IN 46285 USA
关键词
D O I
10.1210/me.16.1.128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ligand-dependent interaction of nuclear receptors and coactivators is a critical step in nuclear receptor-mediated transcriptional regulation. TR-binding protein (TRBP) interacts with nuclear receptors through a single LXXLL motif. Evidence suggested that the sequences flanking the LXXLL motif in a number of coactivators determine receptor selectivity. We performed mutagenesis studies at residues adjacent to the TRBP LXXLL motif and identified S884 of TRBP at the -3 position of the LXXLL motif as a key residue for receptor selectivity. Analysis of in vitro and in vivo receptor interactions with TRBP suggested that S884 allowed selective interactions for ER beta, TR, and RXR vs. ER alpha. Transient transfection studies further confirmed that the LXXLL-binding affinity correlates with TRBP transcriptional activity. Consistent with the structural modeling, an E380G substitution within ERa altered the binding to TRBP mutants, demonstrating the direct contact between TRBP S884 and ERa E380, which is a residue that distinguishes receptor subclasses. Furthermore, S884 can be phosphorylated by MAPK in vitro, an event that significantly altered the binding of TRBP to ER and suggests a potential mechanism for regulatory interaction. As the differential recruitment of TRBP to ERa and ERP may rely on S884, our finding provides insight into estrogen signaling and may lead to the development of therapeutic receptor-selective peptide antagonists.
引用
收藏
页码:128 / 140
页数:13
相关论文
共 55 条
[1]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[2]   Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes [J].
Bramlett, KS ;
Wu, YF ;
Burris, TP .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) :909-922
[3]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[4]  
BURRIS TP, 2000, NUCL RECEPTORS GENET, P1
[5]   Cloning and characterization of RAP250, a novel nuclear receptor coactivator [J].
Caira, F ;
Antonson, P ;
Pelto-Huikko, M ;
Treuter, E ;
Gustafsson, JÅ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5308-5317
[6]  
Chang CY, 1999, MOL CELL BIOL, V19, P8226
[7]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[8]   Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors [J].
Chen, JD ;
Li, H .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1998, 8 (02) :169-190
[9]   Estrogen receptor null mice: What have we learned and where will they lead us? [J].
Couse, JF ;
Korach, KS .
ENDOCRINE REVIEWS, 1999, 20 (03) :358-417
[10]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356